Correction: Pulsed moxifloxacin for the prevention of exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial
نویسندگان
چکیده
Acknowledgements In addition to the authors, the PULSE study group comprised: Pierre Arvis, Bayer Schering Pharma, medical expert; Julie Russell, Bayer Schering Pharma, lead statistician; Barbara Hampel, Bayer Schering Pharma, clinical lead; and Jeff Alder, Bayer HealthCare, lead microbiologist. This study was supported by a research grant from Bayer HealthCare AG. Highfield Communication Consultancy (funded by Bayer HealthCare AG) and Bayer HealthCare AG provided editorial assistance in the preparation of this manuscript. The authors thank Professor Richard Kay for independent statistical assessment. The authors are grateful to the Principal Investigators and their support staff at hospitals and study centres that participated in this research: Argentina: Dr Horacio Ariza, Hosp. Municipal de Agudos "Mi Pueblo", Progreso 2401888 Florencio Varela; Dr Carlos Di Bártolo, Policlínico Bancario, Pulmonar Lab.Av. Gaona 21971416 Buenos Aires; Dr Ramón Ferreyra, Hospital Militar Central "CIR. MY. C. Argerich", Av. Luis M. Campos 7261426 Buenos Aires; Dr Carlos Luna, Hospital de Clínicas "José de San Martín", Av. Córdoba 2351C1120AAF Buenos Aires. Brazil: Prof. Dr Julio Abreu de Oliveira, Universidade Federal de Juiz de Fora-Hospital Universitaro, Pneumology Dept, Rua Catulo Breviglieri, s/n Bairro Santa Catarina, 36036-110 Juiz de Fora; Prof. Dr José de Brito Jardim, UNIFES/EPM, Lar Escola São Francisco Pneumologia, Rua dos Açores, 31004032-060, São Paulo; Prof. Dr Alberto Cukier, Hospital das Clinicas da Faculdade de Medicinada USP, Pulmonary Function Laboratory Pneumology Dept, Av. Dr Enéas de Carvalho Aguiar, 155, 2 andar, bl 1105403-900 São Paulo; Prof. Dr Carlos Fritscher, Pontificia Universidade Católica Centro Clinico Pneumology Service, Av. Ipiranga, 6690-3, and-cj.314Jd. Botánico 906100-000 Porto Alegre. Chile: Dr Manuel Barros, Hospital Carlos van Buren, San Ignacio 725, Valparaiso; Dr Patricia Fernandez, Hospital del Tórax, José Miguel Infante 717, Santiago; Dr María Parada, Clinica Avansalud, Av. Salvador 130, Santiago. France: Docteur Nathan Abenhaim, Cabinet Médical, 35 boulevard Tauler, 67000 Strasbourg; Docteur Alain Bettendorf, Cabinet Médical, 22 rue Gounod, 06000 Nice; Docteur Bernard Bugnas, Cabinet Médical, 3 rue Cronstadt, 06000 Nice; Docteur Gérard Lalanne, Cabinet Médical, 26 rue Martinon, 40000 Mont-de-Marsan; Docteur Alain Queguiner, Cabinet Médical, 3 rue Madame, 64300 Orthez; Docteur Denis Taminau, Cabinet Médical, Bourg 19300 Rosiers d'Egletons; Docteur Pierre Triot, Cabinet Médical, 50 bis rue du 11 Novembre, 62000 Arras. Germany: Hr Dr Klaus Colberg, Kurhausstrabe 1423795 Bad Segeberg; Hr Dr Rolf Dichmann, Theodor-Heuss-Str. 358452 Witten; Hr Dr R Gebhardt, Karl-Marx-Str., 8012043 Berlin; Hr Dr Jörg Groth, DRK Krankenhaus Neuwied, Innere Medizin II Marktstr., 7456564 Neuwied; Dr Gesine Groth, Dr Stefanie Bitter-Suermann, Hr Dr Henrik Watz, Hr Dr Kai Richter, Pneumologisches Forschungsinstitut GmbH am Krankenhaus Großhansdorf Niederlassung Hamburg Jungestr. 1020535 Hamburg; Hr Dr Bernd Kroemer, Alte Weberei, 287600 Kaufbeuren; Fr Dr Anneliese Linnhoff, Hohenzollerndamm 201717, Berlin; Hr Dr Stephan Molitor, Dieterichsstr. 35, B30159 Hannover; Prof. Dr Tom Schaberg, Diakoniekrankenhaus Lungenklinik Unterstedt Zentrum für Pneumologie Verdener Str. 200, 27356 Rotenburg; Hr Dr Winfried Schröder-Babo, Im Ziegelhaus 6-863571 Gelnhausen; Fr. Dr Ulrike Westerhausen, Markgrafenstr. 2010969 Berlin. Israel: Dr Meir Raz, Maccabbi Sick Fund, 37 Katzenelson St., 59512 Bat Yam; Prof. Paul Raz, Haemek Medical Center, 18101 Afula; Dr Zeev Weiler, The Barzilai Medical Center Ashkelon, 3 Hahistadrut Street, 78306 Ashkelon; Dr David Zeltser, Tel Aviv Sourasky Medical Center, 6 Weizman St., 64239 Tel Aviv. Italy: Dr Sergio Harari, Ospedale S. Giuseppe, U.O. di Pneumologia, Via S. Vittore, 1220123 Milano; Prof. Delfino Legnani, Azienda Ospedaliera "Luigi Sacco", U.O. di Pneumologia, Via G.B. Grassi, 7420157 Milano; Dr Alfredo Potena, Azienda Ospedaliera Arcispedale "S. Anna", Fisiopatologia Respiratoria, Corso Giovecca, 20344100 Ferrara; Prof. Ernesto Pozzi, IRCCS Policlinico Universitario San Matteo, Clinica di Malattie dell'Apparato Respiratorio, Piazzale Golgi, 227100 Pavia. Mexico: Mr Dr Raúl Bracamonte Peraza, Clinica Mérida, Av. Itzaes No. 2423 piso, consultorio 303 Col. García Gineres, 97001 Mérida; Mr Dr Francisco Chan Mérida, Hospital General Regional No. 12 "Lic. Benito Juárez" IMSS, Servico de Neumología e Inhaloterapia, Av. Itzaes por Av. Colón S/N, Col. García Gineres, 97070 Mérida; Mr Dr Roberto Perea Sánchez, Hospital Central Universitario, Serv. Medicina Interna/ Neumología, Rosales 3302, Col. Obrera, 31350 Chihuahua; Mr Dr Francisco Sánchez Llamas, Antiguo Hospital Civil de Guadalajara "Fray Antonio Alcalde", Infectious Diseases Department, Hospital No. 278, Torre de Especialidades 7°Piso, Sector Hidalgo, 44640 Guadalajara; Mr Dr Francisco Torre Bolio, Centro Médico de las Américas Consultorio, 111 Calle 54 No. 365 por Av. Pérez Ponce, 97001 Mérida. South Africa: Prof. J. Joubert, Tiervlei Trial Centre, Karl-Bremer Hospital/Ward A1, Mike Pienaar Blvd, Belville, 7531 Cape Town; Dr Justus Killian, WilMed Medical Research Projects, Beuke Oord 28, Wilgers, 0040 Pretoria; Dr Winifred Mans, Clinical Trial Center, 14 Malherbe Street, 7646 Paarl; Dr R Nadar, Parklands Medical Centre, Suite 107, 75 Hopelands Road, Overport, 4090 Durban; Dr G Naude, Dr Jacobus Badenhorst, Unitas Hospital, Clifton Ave., Centurion, 0157 Pretoria; Dr G Nieuwoudt, Kraaifontein Medicross Clinic, Arcadia Centre, Cnr. Brighton & Kipling Street, Kraaifontein, 7569 Cape Town; Dr M Prins, Universitats Hospital, Paul Kruger Street, 9300 Bloemfontein; Dr C Smith, Rochester Place Medical Center, 173 Rivonia Road, Sandton, 2057 Johannesburg; Dr J Viljoen, Genclin Corporation, 56 Reid Street, Westdene, 9301 Bloemfontein. Spain: Dr Luis Alvarez-Sala, Hospital Clínico Universitario San Carlos, C/. Dr Martin Lagos, s/n 28040 Madrid; Dr Félix del Campo, Hospital del Rio Hortega, Avda. Santa Teresa, s/n 47010 Valladolid; Dr Jose Maria Ignacio, Hospital de la Serranía, Ctra. El Burgo, km 129400 Ronda; Dr Rosario Menendez, Hospital Uni* Correspondence: [email protected] 1 Division of Pulmonary, Critical Care and Sleep Medicine, University of Buffalo, State University of New York, Buffalo, NY, USA Full list of author information is available at the end of the article
منابع مشابه
Pulsed moxifloxacin for the prevention of exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial
BACKGROUND Acute exacerbations contribute to the morbidity and mortality associated with chronic obstructive pulmonary disease (COPD). This proof-of-concept study evaluates whether intermittent pulsed moxifloxacin treatment could reduce the frequency of these exacerbations. METHODS Stable patients with COPD were randomized in a double-blind, placebo-controlled trial to receive moxifloxacin 40...
متن کاملDexamethasone vs Hydrocortisone in Management of Exacerbated Chronic Obstructive Pulmonary Disease Patients: A Randomized Controlled Trial
Background: Different types of corticosteroids with different characteristics, such as hydrocortisone and dexamethasone, have been used in treatment of exacerbated chronic obstructive pulmonary disease but drug of choice unclear. The main goal of present study was to compare the efficacy of hydrocortisone and dexamethasone on clinical symptoms, peak expiratory flow, oxidative stress factors and...
متن کاملZabofloxacin versus moxifloxacin in patients with COPD exacerbation: a multicenter, double-blind, double-dummy, randomized, controlled, Phase III, non-inferiority trial
A new quinolone, zabofloxacin, has now been developed; hence, a non-inferiority trial is needed to compare this new compound with another widely used quinolone to examine its efficacy and safety for the treatment of chronic obstructive pulmonary disease (COPD) exacerbations. This was a prospective, multicenter, double-blind, double-dummy, randomized, controlled, parallel-group, Phase III, non-i...
متن کاملEfficacy of Smoking Cessation on Stress, Anxiety, and Depression in Smokers with Chronic Obstructive Pulmonary Disease: A Randomized Controlled Clinical Trial
Background: Stress, anxiety, and depression have been reported as very common comorbidities in smokers with chronic obstructive pulmonary disease (COPD). This study was aimed to investigate the effectiveness of smoking cessation on stress, anxiety, and depression in smokers with COPD. Methods: Three block-randomized controlled trial groups with a block size of 6 and 9 including guided self-chan...
متن کاملPolypharmacy in patients hospitalised for acute exacerbation of COPD.
References 1 Vestbo J, Hurd SS, Agustı́ AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2013; 187: 347–365. 2 Walters JA, Gibson PG, Wood-Baker R, et al. Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2009; 1: ...
متن کاملA novel study design for antibiotic trials in acute exacerbations of COPD: MAESTRAL methodology
Antibiotics, along with oral corticosteroids, are standard treatments for acute exacerbations of chronic obstructive pulmonary disease (AECOPD). The ultimate aims of treatment are to minimize the impact of the current exacerbation, and by ensuring complete resolution, reduce the risk of relapse. In the absence of superiority studies of antibiotics in AECOPD, evidence of the relative efficacy of...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره 11 شماره
صفحات -
تاریخ انتشار 2010